首页> 美国卫生研究院文献>Heliyon >An exploratory investigation of antibodies to NMDA-type glutamate receptor subunits in serum and cerebrospinal fluid among psychiatric patients with anti-thyroid antibodies
【2h】

An exploratory investigation of antibodies to NMDA-type glutamate receptor subunits in serum and cerebrospinal fluid among psychiatric patients with anti-thyroid antibodies

机译:抗甲状腺抗体患者血清和脑脊液中NMDA型谷氨酸受体亚基抗体的探索性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hashimoto's thyroiditis, which is characterized by anti-thyroid antibodies such as the anti-thyroglobulin (Tg) antibody and anti-thyroid peroxidase (TPO) antibody, is one of the autoimmune diseases associated with psychiatric illnesses. We previously reported a high prevalence of antibodies to N-terminals of N-methyl-D-aspartate (NMDA) type glutamate receptor (GluR) subunits (GluN1-NT and GluN2B-NT2) among psychiatric patients with anti-thyroid antibodies. However, it remains unclear whether the presence of anti-thyroid antibodies influences antibodies to GluN1-NT or GluN2B-NT2 among psychiatric patients. The present study aims to examine antibodies to GluN1-NT and GluN2B-NT2 in psychiatric patients with anti-thyroid antibodies (PPATs) and in those without (non-PPATs).
机译:散列瘤的甲状腺炎,其特征在于抗甲状腺抗体,如抗甲状腺球蛋白(Tg)抗体和抗甲状腺过氧化物酶(TPO)抗体,是与精神疾病相关的自身免疫疾病之一。我们之前报道了对抗甲状腺抗体的精神科患者的抗甲状腺患者的N-甲基-D-天冬氨酸(NMDA)型谷氨酸(NMDA)型谷氨酸受体(GLUN1-NT和GLUN2B-NT2)的抗体高患病率。然而,仍然不清楚抗甲状腺抗体是否存在对精神病患者中的抗体对GLUN1-NT或GLUN2B-NT2的抗体。本研究旨在将抗甲状腺抗体(PPATS)和抗甲状腺抗体(PPATS)的精神病患者和抗体(非PPATS)中的抗体检查抗体和GLUN2B-NT2的抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号